Lead levels in human milk and children's health risk: a systematic review

Gina Ayumi Kobayashi Koyashiki1, Monica Maria Bastos Paoliello, Paul B Tchounwou

  • 1Department of Collective Health, Health Science Center, State University of Londrina, Parana, Brazil. ginakoyashiki@yahoo.com.br

Insights

This study reviewed lead (Pb) levels in human breast milk, finding significant variability. Human milk can serve as a biomarker for assessing children's lead poisoning risk.

Area of Science:

  • Environmental Health
  • Toxicology
  • Pediatrics

Background:

  • Lead (Pb) is a toxic metal causing severe developmental deficits in children.
  • Children's primary exposure routes are contaminated food, water, and soil.
  • Limited research exists on lead exposure risks via breast milk consumption.

Purpose of the Study:

  • To systematically review epidemiologic studies on lead levels in human breast milk.
  • To analyze study designs and analytical procedures for lead assessment.
  • To evaluate the potential risk of lead exposure through breast milk.

Main Methods:

  • Systematic literature review of epidemiologic studies published since the 1980s.
  • Inclusion criteria applied to 112 selected articles, with 11 meeting requirements.
  • Analysis of study designs, sample collection, and lead assessment protocols.

Main Results:

  • Lead levels in mature milk ranged from 0.15 to 6.1 microg L(-1).
  • Colostrum samples showed higher lead levels, from 0.48 to 14.6 microg L(-1).
  • The lead milk/blood ratio varied significantly (0.01–0.48), indicating diverse transfer efficiencies.

Conclusions:

  • Heterogeneity in study methods highlights the need for standardized protocols.
  • Human milk is a relevant biological matrix for assessing lead poisoning risk in children.
  • Further research with harmonized methods is crucial for accurate risk assessment.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
The Periodic Table and Organismal Elements01:27

The Periodic Table and Organismal Elements

Elements are the smallest units of matter that cannot be broken down further by chemical processes. There are 118 known elements, but not all of these are naturally occurring, and only a few of them are essential for life. Living matter is composed primarily of carbon, nitrogen, hydrogen, and oxygen, with smaller amounts of other elements like calcium, phosphorus, potassium, and sulfur. Other elements are also necessary for life but only in trace amounts.
Periodic Table Provides Information...
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...